在性别肯定性丸激素治疗后生殖能力
Hadrian M Kinnear1,2, Molly B Moravek3,4
1Program in Cellular and Molecular Biology, University of Michigan, Ann Arbor, MI, USA.
Human reproduction (Oxford, England)
|August 12, 2023
概括
接受丸激素治疗的跨性别者可能会面临生育保护障碍. 需要对的更多研究.
科学领域:
- 生殖内分泌学和跨性别健康.
- 研究激素治疗对生殖能力的影响.
背景情况:
- 跨性别者和非二进制个体在出生时被分配为女性,经常使用丸激素疗法进行男性化.
- 在开始丸激素之前,建议保持生育能力,但存在进入障碍.
- 一些个人可能希望在使用丸激素后在未来生殖,这引发了关于生殖结果的问题.
研究的目的:
- 探索长期男性化丸激素治疗对跨性别和非二进制个体的生殖影响.
- 突出了解的可逆性和功能影响在生殖系统上的必要性.
主要方法:
- 对怀孕和丸激素治疗后个人辅助生殖的新兴文献的审查.
- 分析当前关于丸激素对卵巢,子宫和输卵管功能的影响的知识差距.
主要成果:
- 有限但新出现的证据表明,在使用丸激素后,成功怀孕和辅助生殖是可能的.
- 对生殖器官 (卵巢,子宫,输卵管) 的确切影响以及这些变化的可逆性仍然不清楚.
- 预测丸激素治疗后个体的成功生殖结果尚未确立.
结论:
- 关于男性化丸激素治疗的长期生殖后果,仍然存在重大问题.
- 进一步的研究是优先考虑的,以了解对生殖能力的影响,并为生育保护咨询提供信息.
更多相关视频
相关概念视频
Testosterone: Functions and Regulation
745
The intricate hormonal interplay essential for male reproductive health begins with the release of gonadotropin-releasing hormone (GnRH) by the hypothalamus. This hormone prompts the pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). LH targets the Leydig cells in the testes, stimulating them to produce and release testosterone. In concert with testosterone, FSH acts on the Sertoli cells within the seminiferous tubules to facilitate the release of...
745
Menopause
201
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
201
Signs of Puberty
423
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
423
Infertility in Males
295
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
295
Disorders of the Male Reproductive System
462
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
462
Spermatogenesis
102.7K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.7K


